Inventor · disambiguated record
Kathleen R. Whitten
Also filed as: WHITTEN KATHLEEN R
25 granted patents·116 citations·filing 1985–2002
95Inventor score
Top patents by PatentIndex Score
25 records- 0180US5705647AIntermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 1996·Granted Jan 6, 1998·24 cites·4 claims
- 0280US4931447ACycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolinesLILLY CO ELI·Filed 1989·Granted Jun 5, 1990·16 cites·44 claims
- 0377US5962725AIntermediate compounds useful for making HIV protease inhibitors such as nelfinavirAGOURON PHARMA·Filed 1997·Granted Oct 5, 1999·14 cites·2 claims
- 0464US5925759AMethods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 1997·Granted Jul 20, 1999·6 cites·12 claims
- 0563US6512135B2Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2002·Granted Jan 28, 2003·1 cites·6 claims
- 0663US6316625B1Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2000·Granted Nov 13, 2001·1 cites·18 claims
- 0757US6117999AMethods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHRAMACEUTICALS INC·Filed 1999·Granted Sep 12, 2000·5 cites·4 claims
- 0854US6303786B1Processes for making nelfinavir mesylateAGOURON PHARMA·Filed 1999·Granted Oct 16, 2001·3 cites·14 claims
- 0953US4683236ACycloalkanol esters of dihydrolysergic acid useful as 5Ht2 receptor antagonistsLILLY CO ELI·Filed 1985·Granted Jul 28, 1987·4 cites·3 claims
- 1052US6605721B2Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2002·Granted Aug 12, 2003·0 cites·19 claims
- 1151US6465661B1Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2002·Granted Oct 15, 2002·0 cites·4 claims
- 1251US6084107AIntermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 1997·Granted Jul 4, 2000·4 cites·5 claims
- 1351US4762842ASelective method for blocking 5HT2 receptorsLILLY CO ELI·Filed 1987·Granted Aug 9, 1988·16 cites·14 claims
- 1450US6407285B1Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2001·Granted Jun 18, 2002·0 cites·2 claims
- 1549US6392067B1Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2001·Granted May 21, 2002·0 cites·7 claims
- 1649US4713384ASelective method for blocking 5HT2 receptorsLILLY CO ELI·Filed 1985·Granted Dec 15, 1987·5 cites·2 claims
- 1739US4906639ACycloalkanol esters of dihydrolysergic acidLILLY CO ELI·Filed 1989·Granted Mar 6, 1990·1 cites·8 claims
- 1838US4714704AAlkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonistsLILLY CO ELI·Filed 1985·Granted Dec 22, 1987·6 cites·4 claims
- 1935US4939258ACycloalkanol esters of dihydrolysergic acidLILLY CO ELI·Filed 1990·Granted Jul 3, 1990·1 cites·1 claims
- 2034US4810710A4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraineLILLY CO ELI·Filed 1988·Granted Mar 7, 1989·3 cites·2 claims
- 2133US4968802AProcess of making alkoxy cycloalkanol esters of dihydrolysergic acidLILLY CO ELI·Filed 1990·Granted Nov 6, 1990·3 cites·1 claims
- 2232US4914100AAlkoxy cycloalkanol esters of dihydrolysergic acidLILLY CO ELI·Filed 1989·Granted Apr 3, 1990·2 cites·1 claims
- 2331US4847261AAlkoxy cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonists propertiesLILLY CO ELI·Filed 1988·Granted Jul 11, 1989·1 cites·16 claims
- 2431US4845224ACycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonist propertiesLILLY CO ELI·Filed 1987·Granted Jul 4, 1989·0 cites·8 claims
- 2530US4704396APhenacyl esters of 1-substituted-6-(substituted and unsubstituted) dihydrolysergic acids useful as 5HT receptor antagonistsLILLY CO ELI·Filed 1985·Granted Nov 3, 1987·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →